Skip to Main Content
Welcome to the Marketplace

Go to Main Navigation

Amarantus BioScience Holdings, Inc.

San Francisco, CA, US
Company Type:
Small Business (1-10M TTM Revenue)

Amarantus BioScience Holdings, Inc. is a publicly traded biotechnology company focused on developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology.

The Company’s lead therapeutic program, eltoprazine is a small molecule indicated for the treatment of Levodopa-induced dyskinesia, one of the most difficult problems facing patients with Parkinson’s disease. Eltoprazine is currently in a Phase 2b clinical trial with results from the study expected in 2016. Eltoprazine is also being evaluated for the treatment of adult attention deficit hyperactivity disorder (ADHD) and Alzheimer’s aggression.

Site Badges
Amarantus BioScience Holdings, Inc.
655 Montgomery Street San Francisco, CA, 94111 United States

Get started

If your organization has a marketplace, you can log in here to order products and services directly.

If you're interested in ordering custom research services from suppliers in the network, book a meeting with our team here.

To order products instantly, request access below.

Password must:

• Be at least 12 characters in length

• Contain a lowercase letter (a-z)

• Contain an uppercase letter (A-Z)

• Contain a numeral (0-9)

• Contain a special character (%, $, !, @)

By signing up for this account you agree to the Terms of Service